Karnataka should explore dedicated investment mechanisms for BT: Mazumdar-Shaw

Karnataka should explore dedicated biotechnology investment mechanisms while embedding artificial intelligence across the biotechnology value chain to unlock new opportunities in drug discovery, diagnostics, precision medicine, and biomanufacturing, said Kiran Mazumdar-Shaw, Chairperson, Vision Group on Biotechnology.
View Article

Registration Closed

Thank you for your interest in joining us for the event.
Registrations are now closed as we have reached full capacity.

However, you can still be part of the experience by tuning in to the live coverage of the sessions on our YouTube channel
Stay connected:
Follow us on
join our WhatsApp Channel
https://chat.whatsapp.com/ I8NAiHQX6tFJwuhklRo97T for updates and highlights
Thank you once again for your support